Case Western Reserve School of Medicine is the medical school of Case Western Reserve University, a private research university in Cleveland, Ohio. It is the largest biomedical research center in Ohio.

During the past decade, Case Western Reserve University School of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Case Western Reserve University School of Medicine" #1 sponsor was "Andrea Gropman" with 1 trials, followed by "Athersys, Inc" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "GRADE Study Group" with 1 trials sponsored and "GlaxoSmithKline" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Case Western Reserve University School of Medicine" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Rare Diseases Clinical Research Network" with 2 trials as a collaborator and "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Case Western Reserve University School of Medicine" are "HIV Infections" (2 trials), "Urea Cycle Disorders" (2 trials), "Amino Acid Metabolism, Inborn Errors" (1 trials), "Bipolar Disorder" (1 trials) and "Brain Diseases, Metabolic, Inborn" (1 trials). Many other conditions were trialed in "Case Western Reserve University School of Medicine" in a lesser frequency.

Most popular intervention types in "Case Western Reserve University School of Medicine" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "DPP-4 inhibitor (sitagliptin)" (1 trials), "Dapsone" (1 trials), "E5564" (1 trials) and "GLP-1 receptor agonist (liraglutide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Case Western Reserve University School of Medicine" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Case Western Reserve University School of Medicine". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Case Western Reserve University School of Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Case Western Reserve University School of Medicine, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".